These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 2624491

  • 1. [Action of vasoactive drugs in male sexual impotence].
    Morales JC, Elizondo B.
    Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
    [Abstract] [Full Text] [Related]

  • 2. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y, Lidgi S, Moskovitz B, Levin RD.
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [Abstract] [Full Text] [Related]

  • 3. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R, Asakawa M, Kawashima H, Yoshimura R, Maekawa T, Kashiwara N, Tanaka H, Nishio S.
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [Abstract] [Full Text] [Related]

  • 4. Biweekly intracavernous administration of papaverine for erectile dysfunction.
    Mooradian AD, Morley JE, Kaiser FE, Davis SS, Viosca SP, Korenman SC.
    West J Med; 1989 Nov; 151(5):515-7. PubMed ID: 2603417
    [Abstract] [Full Text] [Related]

  • 5. [Intracavernous pharmacotherapy for organic impotence in the elderly].
    Richter S, Shalev M, Nissenkorn I.
    Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E, Israilov S, Shmueli J, Simon D, Baniel J, Livne P.
    Harefuah; 1998 May 01; 134(9):673-8, 750. PubMed ID: 10909609
    [Abstract] [Full Text] [Related]

  • 7. [Prostaglandin E1 in erectile dysfunction].
    Porst H.
    Urologe A; 1989 Mar 01; 28(2):94-8. PubMed ID: 2655258
    [Abstract] [Full Text] [Related]

  • 8. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
    Momose H, Natsume O, Yamamoto M, Suemori T, Yamada K.
    Hinyokika Kiyo; 1987 Jul 01; 33(7):1065-9. PubMed ID: 3687629
    [Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S, Iwai Y, Yasumoto R, Matsuda J, Kawano M, Omachi T, Kono T, Yamamoto S, Sakakura T, Minami H.
    Hinyokika Kiyo; 1994 Jan 01; 40(1):37-41. PubMed ID: 7509119
    [Abstract] [Full Text] [Related]

  • 10. Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury.
    Lloyd LK, Richards JS.
    Paraplegia; 1989 Dec 01; 27(6):457-64. PubMed ID: 2608299
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W, de la Fuente RB, Lycklama à Nijeholt AA, Vermeij P, Zwartendijk J.
    Int J Impot Res; 1996 Mar 01; 8(1):5-7. PubMed ID: 8735187
    [Abstract] [Full Text] [Related]

  • 12. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
    Ferrière JM, Gaston R, Piechaud T, Le Guillou M.
    Ann Urol (Paris); 1988 Mar 01; 22(1):57-9. PubMed ID: 3369847
    [Abstract] [Full Text] [Related]

  • 13. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K, Brekke I, Christiansen E.
    Int J Impot Res; 1996 Mar 01; 8(1):9-16. PubMed ID: 8735188
    [Abstract] [Full Text] [Related]

  • 14. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ, de Meyer JM, de Sy WA, Claessens H.
    Paraplegia; 1986 Oct 01; 24(5):271-5. PubMed ID: 3774363
    [Abstract] [Full Text] [Related]

  • 15. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM, Stevenson RW, Szasz G.
    J Urol; 1989 Mar 01; 141(3):549-50. PubMed ID: 2918589
    [Abstract] [Full Text] [Related]

  • 16. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q, Yao DH, Jiang YQ.
    Asian J Androl; 2000 Dec 01; 2(4):301-3. PubMed ID: 11202421
    [Abstract] [Full Text] [Related]

  • 17. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
    Chandeck Montesa K, Chen Jiménez J, Tamayo JC, Rodríguez Antolín A, Alvarez González E.
    Actas Urol Esp; 1992 Mar 01; 16(3):208-16. PubMed ID: 1621545
    [Abstract] [Full Text] [Related]

  • 18. Intracavernous injections for impotence.
    Med Lett Drugs Ther; 1987 Oct 23; 29(751):95-6. PubMed ID: 3670212
    [No Abstract] [Full Text] [Related]

  • 19. Impotence: treatment by autoinjection of vasoactive drugs.
    Williams G, Mulcahy MJ, Kiely EA.
    Br Med J (Clin Res Ed); 1987 Sep 05; 295(6598):595-6. PubMed ID: 3117249
    [Abstract] [Full Text] [Related]

  • 20. Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic.
    Armstrong DK, Convery A, Dinsmore WW.
    Int J STD AIDS; 1993 Sep 05; 4(4):214-6. PubMed ID: 8399501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.